Clearmind Medicine (Clearmind Medicine) Net Cash per Share : $1.36 (As of Jan. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Clearmind Medicine Net Cash per Share?

Net Cash per Share is calculated as Cash, Cash Equivalents, Marketable Securities minus Total Liabilities minus Minority Interest and then divided by Shares Outstanding (EOP). Clearmind Medicine's Net Cash per Share for the quarter that ended in Jan. 2024 was $1.36.

The historical rank and industry rank for Clearmind Medicine's Net Cash per Share or its related term are showing as below:

CMND' s Price-to-Net-Cash Range Over the Past 10 Years
Min: 0.83 Med: 5.63 Max: 118.18
Current: 0.83

During the past 7 years, the highest Price-to-Net-Cash Ratio of Clearmind Medicine was 118.18. The lowest was 0.83. And the median was 5.63.

CMND's Price-to-Net-Cash is ranked better than
89.4% of 849 companies
in the Biotechnology industry
Industry Median: 4 vs CMND: 0.83

Clearmind Medicine Net Cash per Share Historical Data

The historical data trend for Clearmind Medicine's Net Cash per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clearmind Medicine Net Cash per Share Chart

Clearmind Medicine Annual Data

Trend

Oct17

Oct18

Oct19

Oct20

Oct21

Oct22

Oct23

Net Cash per Share

Get a 7-Day Free Trial

-2.68

11.14

82.11

-26.89

0.65

Clearmind Medicine Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
Net Cash per Share	Get a 7-Day Free Trial															32.61	8.56	7.34	0.65	1.36

Competitive Comparison of Clearmind Medicine's Net Cash per Share

For the Biotechnology subindustry, Clearmind Medicine's Price-to-Net-Cash, along with its competitors' market caps and Price-to-Net-Cash data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Clearmind Medicine's Price-to-Net-Cash Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Clearmind Medicine's Price-to-Net-Cash distribution charts can be found below:

* The bar in red indicates where Clearmind Medicine's Price-to-Net-Cash falls into.

Clearmind Medicine Net Cash per Share Calculation

In the calculation of a company's Net Cash per Share, assets other than cash and short term investments are considered to be worth nothing. But the company has to pay its debt and other liabilities in full. This is an extremely conservative way of valuation. Most companies have negative Net Cash per Share. But sometimes a company's price may be lower than its net-cash.

Clearmind Medicine's Net Cash per Share for the fiscal year that ended in Oct. 2023 is calculated as

	Net Cash per Share (A: Oct. 2023 )
=	(Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(3.987	-	3.594	-	0)	/	0.60734
=	0.65

Clearmind Medicine's Net Cash per Share for the quarter that ended in Jan. 2024 is calculated as

	Net Cash per Share (Q: Jan. 2024 )
=	(Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(9.373	-	5.056	-	0)	/	3.16957
=	1.36

Clearmind Medicine (NAS:CMND) Net Cash per Share Explanation

Ben Graham invested in situations where the company's stock price was lower than its net-cash. He assigned some value to the company's other current asset. The value is called Net Current Asset Value (NCAV). One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham's strategy produced similar results.

You can find companies that are traded below their Net Current Asset Value (NCAV) with our Net-Net screener.

Clearmind Medicine Net Cash per Share Related Terms

Thank you for viewing the detailed overview of Clearmind Medicine's Net Cash per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Clearmind Medicine (Clearmind Medicine) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Clearmind Medicine Inc (NAS:CMND) » Definitions » Net Cash per Share

Comparable Companies

Traded in Other Exchanges

CWY0:Germany CWY0:Germany CMND:Canada

Address

101-1220 West 6th Avenue, Vancouver, BC, CAN, V6H 1A5

Website

https://www.clearmindmedicine.com

Clearmind Medicine Inc is a psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize them as regulated medicines, foods, or supplements. The company's intellectual portfolio currently consists of four patent families. The company intends to seek additional patents for its compounds whenever warranted and will remain opportunistic regarding the acquisition of additional intellectual property to build its portfolio.